Stock Quote
Teva Pharmaceutical Industries Ltd (TEVA.TA) (Tel Aviv Stock Exchange)
20,300.00₪
24 Nov 2009
+0.69%
20,160.00₪
20,170.00₪
445,879
20,300.00₪
20,100.00₪
21,200.00₪
15,680.00₪
0.27
478,372
TEVA.TA
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Hurvitz, Eli | Chairman of the Board | -- |
| Yanai, Shlomo | Chief Executive Officer, President | -- |
| Frost, Phillip | Vice Chairman of the Board | -- |
Profile
Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson’s... Full Description
Company Address
Teva Pharmaceutical Industries Ltd
5 Basel Street
PO Box 3190
Petach Tikva 49131
P: +9723.9267267
F: +9723.9267472
5 Basel Street
PO Box 3190
Petach Tikva 49131
P: +9723.9267267
F: +9723.9267472
Analyst Research
| TEVA.TA | Industry | |
|---|---|---|
| P/E(TTM) | 57.58 | 3.60 |
| P/S(TTM) | 3.63 | 0.57 |
| ROI(TTM) | 4.18 | 1.86 |
| ROE(TTM) | 5.47 | 2.52 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | 3.15 |
| Total Revenue | $13,412.79M |
| Net Income | $2,463.42M |
| EPS | $2.68 |
